About Parse Biosciences
Parse Biosciences is a Healthcare company based in Seattle (United States) founded in 2018 by Geoff Krummel, Charlie Roco, and Alex Rosenberg. RNA-sequencing transcriptome kits for health data analysis are developed. Parse Biosciences has raised $100.26 million across 7 funding rounds from investors including Marshall Wace, Janus Henderson Investors and Horizon Tech Finance. Parse Biosciences has completed 1 acquisition, including Biomage. Its chief executive, as recorded, is Alex Rosenberg. Its website parsebiosciences.com draws about 63 thousand monthly visits. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its competitors include Neogen, GenScript and Fluent BioSciences; 3 of its 3 listed competitors have raised funding.
Company details
Parse Biosciences was founded in 2018 in Seattle, United States, within the biotechnology sector. RNA-sequencing solution-based kits are developed for transcriptome analysis of health data. Solutions are provided to enable researchers to process fixed samples from various collection dates in one experiment, with oversight on sample handling to minimize errors. Barcoding is applied to label single-cell or single-nucleus suspensions for sequencing, complemented by data analysis tools.
- Headquarters Seattle, United States
- Founders Geoff Krummel, Charlie Roco, Alex Rosenberg
- SectorsHealthcare
- Email••••••••
- Website parsebiosciences.com
- Social LinkedIn X
- Total Equity Funding$100.26M (USD)
in 7 rounds
- InvestorsMarshall Wace
& 8 more
- Investments & Acquisitions
Funding Insights of Parse Biosciences
Parse Biosciences has successfully raised a total of $100.26M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $100.26M
- Total Rounds 7
- First Round $1.2M
(Oct 2018)
- Investors Count 9
All 7 funding rounds of Parse Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2023 | Debt – Conventional | – | – | ||
| Dec 2023 | $50M | Series C | – | Soleus Capital | |
| Feb 2022 | $41.5M | Series B | – | Janus Henderson Investors, Marshall Wace | |
| Jan 2021 | $7M | Series A | – | Bioeconomy Capital | – |
| Sep 2019 | $560,000 | Seed | – | – | – |
| Feb 2019 | $225,000 | Grant | – | – | |
| Oct 2018 | $1.2M | Seed | – | – | – |
9 investors in total: 9 institutional.
Investors in Parse Biosciences
Parse Biosciences has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Marshall Wace, Janus Henderson Investors and Horizon Tech Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| soleuscapital.com | ||||
| bioeconomycapital.com | ||||
Multiple sectors are targeted for venture capital investments. | 1934 | janushenderson.com | London, United Kingdom | |
Long-short equity strategies are managed through specialized hedge funds. | 1997 | mwam.com | London, United Kingdom | |
Investments in multiple sectors are made by Sahsen Ventures. | sahsen.com | Seattle, United States | ||
Structured debt is provided to life sciences and technology firms. | 2004 | horizontechfinance.com | Farmington, United States | |
Private equity fund focused on the biotechnology sector | logoscapital.com | San Francisco, United States | ||
Saras Capital LLP is engaged in UK investment advisory services. | sarascapital.com | United Kingdom | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Parse Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Parse Biosciences
38 people are tracked at Parse Biosciences (12 in leadership, 26 in team).
| Name | Role | Group |
|---|---|---|
Geoff Krummel | Co-Founder | Leadership |
Charlie Roco | Co-Founder & CTO | Leadership |
Alex Rosenberg | Co-Founder & CEO | Leadership |
Danielle Zapparelli | Associate Director Of Supply Chain | Leadership |
Michael Skogen | Vice President Of Sales | Leadership |
Pravesh Thapa | Director Of Manufacturing | Leadership |
Hoai Nguyen | Senior Director Of Automation | Leadership |
Nam Tran | Vice President Of Operations | Leadership |
Ramon Maghsoudi | Director, Digital Marketing & Operations | Leadership |
Tanya Kappen | Head Of Human Resources | Leadership |
Lisa Owen | Senior Director Of Marketing | Leadership |
Kaitie Vandenheuvel-Kramer | Vice President Marketing | Leadership |
Calum Marrs | District Sales Manager - EMEA | Team |
Mai Le | Senior Buyer | Team |
Oliver Sanderson | Senior Automation Engineer | Team |
Gokhan Demirkan | Senior Product Manager | Team |
Olivia Shaw | Regional Marketing Manager | Team |
Ryan Wall | Technical Sales Manager - Cambridgeshire & Scotland | Team |
Tammy L. | Sr. Event And Marketing Manager | Team |
Maya Skolnik | Senior Recruiting Manager | Team |
18 more people are available in the full profile.
Complete people profiles for Parse Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Parse Biosciences
Parse Biosciences has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Biomage.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of a cloud-based cell and genomic sequence analysis platform for researchers | biomage.net | Glasgow, United Kingdom | 2019 | Jan 2024 | •••• |
Complete acquisition details for Parse Biosciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Parse Biosciences
4 dated milestones of Parse Biosciences across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Parse Biosciences is founded.
- Funding First funding round of $1.2M.
- Funding Latest funding round, Debt – Conventional,.
- Acquisition Acquires Biomage.
Competitors of Parse Biosciences
Parse Biosciences has 3 listed competitors in our database, 3 of them funded. They include Neogen, GenScript and Fluent BioSciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neogen.com | 1982 | Lansing, United States | $700,000 | 2,640 | Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing | |
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| fluentbio.com | 2018 | Watertown, United States | $19M | Proprietary reagents for single-cell genetic analysis are developed. |
Detailed competitors of Parse Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Parse Biosciences
The website of Parse Biosciences (parsebiosciences.com) receives about 62.7K visits a month.
- Monthly visits62.7K
▼ 16.8% vs previous month
Websites whose visitors overlap most with Parse Biosciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| cyrusbio.com | 100% | 1.9K | #9,105,938 | View details | |
panglaodb.se | panglaodb.se | 90% | #2,014,103 | – | |
immunarch.com | immunarch.com | 90% | #4,946,938 | – | |
berthold-jp.com | berthold-jp.com | 86% | #5,542,298 | – | |
creative-biolabs.com | creative-biolabs.com | 85% | #348,062 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 26 similar websites and full traffic analytics for Parse Biosciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 26 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Parse Biosciences (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Parse Biosciences
Complete news archive for Parse Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Parse Biosciences
Parse Biosciences was founded in 2018.
Parse Biosciences is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Alex Rosenberg is the CEO of Parse Biosciences, as recorded in our data. They have also founded this company.
Parse Biosciences is a funded company, having raised a total of $100.26M across 7 funding rounds to date. The company's 1st funding round was a Seed of $1.2M, raised on Oct 2018.
Parse Biosciences was founded in 2018 in Seattle, United States, within the biotechnology sector. RNA-sequencing solution-based kits are developed for transcriptome analysis of health data. Solutions are provided to enable researchers to process fixed samples from various collection dates in one experiment, with oversight on sample handling to minimize errors. Barcoding is applied to label single-cell or single-nucleus suspensions for sequencing, complemented by data analysis tools.
Parse Biosciences's top competitors include Neogen, GenScript and Fluent BioSciences.
Parse Biosciences has made 1 acquisition, including Biomage.
Parse Biosciences has 9 investors. Key investors include Marshall Wace, Janus Henderson Investors, Horizon Tech Finance, Soleus Capital, and Bioeconomy Capital.